Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 5,250,400 | 4,798,900 | 3,276,400 | 2,518,600 | 2,077,370 |
| Cost of Goods | 2,769,800 | 2,559,600 | 1,757,500 | 1,423,200 | 1,230,070 |
| Gross Profit | 2,480,600 | 2,239,300 | 1,518,900 | 1,095,400 | 847,290 |
| Operating Expenses | 1,168,500 | 1,632,100 | 734,600 | 571,600 | 470,900 |
| Operating Income | 1,312,900 | 607,800 | 784,800 | 524,000 | 376,470 |
| Interest Expense | 0 | 0 | 5,000 | 0 | 0 |
| Other Income | -4,300 | -4,100 | 92,600 | -24,600 | -36,120 |
| Pre-tax Income | 1,308,600 | 603,700 | 872,400 | 499,400 | 340,350 |
| Income Tax | 236,200 | 267,200 | 181,500 | 84,800 | 63,650 |
| Net Income Continuous | 1,072,300 | 1,012,700 | 617,800 | 410,300 | 286,138 |
| Net Income | $1,072,300 | $331,800 | $691,000 | $410,300 | $278,210 |
| EPS Basic Total Ops | 1.73 | 0.54 | 1.29 | 0.78 | 0.53 |
| EPS Basic Continuous Ops | 1.73 | 1.65 | 1.15 | 0.78 | 0.54 |
| EPS Diluted Total Ops | 1.59 | 0.48 | 1.20 | 0.76 | 0.51 |
| EPS Diluted Continuous Ops | 1.58 | 1.47 | 1.05 | 0.73 | 0.51 |
| EBITDA(a) | $1,312,900 | $607,800 | $912,500 | $524,000 | $376,470 |